Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-22
1996-06-25
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546226, A61K 31445, C07D21106
Patent
active
055300120
ABSTRACT:
Novel 3-alkoxybenzylpiperidines have melatonergic properties. They are believed useful in treating depression, jet-lag, work-shift syndrome, sleep disorders, glaucoma, some disorders associated with reproduction, cancer, immune disorders and neuroendocrine disorders.
REFERENCES:
patent: 4719219 (1988-01-01), Arvidsson et al.
patent: 5071875 (1991-12-01), Horn et al.
patent: 5194614 (1993-03-01), Andrieux et al.
patent: 5225442 (1993-07-01), Andrieux et al.
patent: 5240919 (1993-08-01), Yous et al.
patent: 5300507 (1994-04-01), Yous et al.
patent: 5308866 (1994-05-01), Lesieur et al.
patent: 5318994 (1994-06-01), Andrieux et al.
patent: 5322843 (1994-06-01), Yous et al.
patent: 5322849 (1994-06-01), Yous et al.
patent: 5326775 (1994-07-01), Yous et al.
Lange's Handbook of Chemistry, Section 1, Table 1.16 (1972).
Cardellini et al. "Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors" Farmaco Ed. Sc. v. 42, pp. 307-317 (1987).
Cassone et al, "Dose-Dependent Entrainment of Rat Circadian Rhythms by Daily Injection of Melatonin", J. Biol. Rhythms, vol. 1., No. 3, (1986) pp. 219-229.
Arendt et al, "Alleviation of Jet Lag by Melatonin: preliminary results of controlled double blind trial", Br. Med. J. vol. 292, 1986) p. 1170.
Begue et al, "Syntheses dans la serie de l'aza-2 bicyclo[2,2,2]octane (isoquinuclidine)", Bulletin de La Societe Chimque de France, No. 3, (1969) pp. 781-787. (French).
Catt John D.
Keavy Daniel J.
Mattson Ronald J.
Bristol-Myers Squibb Co.
Chang Ceila
Nolan Sandra M.
LandOfFree
3-alkoxybenzylpiperidine derivatives as melatonergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-alkoxybenzylpiperidine derivatives as melatonergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-alkoxybenzylpiperidine derivatives as melatonergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189053